A Win For Kaleido Biosciences, Inc.
Wed, Apr 13, 2022 at 05:30 PM
Kaleido Biosciences, Inc. (KLDO:NASDAQ) rocketted at $0.3, a gain of 75.1%. On Tue, Apr 12, 2022, KLDO:NASDAQ touched a New 2-Week Low of $0.17. The stock appeared on our News Catalysts scanner on Mon, Mar 28, 2022 at 05:27 PM in the 'MISCELLANEOUS' category. From Tue, Mar 29, 2022, the stock recorded 10.00% Up Days and 18.18% Green Days
About Kaleido Biosciences, Inc. (KLDO:NASDAQ)
Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbiome organ to treat disease and improve human health. Its product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome.
Top 10 Gainers:
- Kaleido Biosciences, Inc. (KLDO:NASDAQ), 75.06%
- Antares Pharma, Inc. (ATRS:NASDAQ), 49.2%
- Veru Inc. (VERU:NASDAQ), 42.86%
- Sierra Oncology, Inc. (SRRA:NASDAQ), 38.54%
- Biofrontera Inc. (BFRI:NASDAQ), 34.05%
- Creatd Inc. (CRTD:NASDAQ), 33.14%
- HighPeak Energy Inc. (HPK:NASDAQ), 31.76%
- Planet Green Holdings Corp. (PLAG:NYSEMKT), 26.8%
- Turning Point Therapeutics, Inc. (TPTX:NASDAQ), 25.13%
- Hallador Energy Company (HNRG:NASDAQ), 25.06%